↓ Read PDF
01 · ABSTRACT

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most common neuropsychiatric disorder in childhood affecting 5-6% of children, and is a major global health concern, which seems to increase in magnitude. The etiology of ADHD is still poorly understood, however; there are indications of genetic as well as environmental and epigenetic factors contributing to the development of the disorder. The objectives of this study was i) to identify potential ADHD candidate genes; ii) to explore spatial and temporal transcriptional fluctuation of the identified ADHD candidate genes in normal developing human brain tissues, and iii) to identify miRNAs regulating the identified ADHD candidate genes and explore how these miRNAs are expressed in normal developing human brain tissues.

From search in literature and publicly available databases, we identified 103 shared potential ADHD candidate genes. These genes were expressed and enriched in several human brain regions and developmental stages. Clustering analysis of these genes based on their expression levels showed a clear difference between fetal stage and the other developmental stages. There was no clear gender or brain region differences between samples. Further, functional analysis of these genes revealed that they participate in a variety of different and widely distributed functional pathways implicated with ADHD.

From miRNA-target prediction analysis, we identified twenty miRNAs regulating the identified 103 genes, and the expression pattern of these miRNAs was developmental stage dependent. These miRNAs were enriched in functional pathways and disease ontologies relevant to neurodevelopment.

The knowledge of the expression pattern of potential ADHD candidate genes and miRNAs, which regulate these genes across different stages of brain development, is essential for understanding normal brain development and subsequent disease development of the brain. In addition, identification of miRNA-regulated ADHD candidate genes can be used to develop blood-based molecular markers to be investigated in future studies of ADHD patients.   

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 8 No 9 (2020): Vol.8 Issue 9, September, 2020
SectionResearch Articles
Published25 September 2020
DOI10.18103/mra.v8i9.2214
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

LD

Lene B. Dypås

Section for Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health

KG

Kristine B. Gutzkow

Section for Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health

AO

Ann-Karin Olsen

Section for Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health

ND

Nur Duale

Section for Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗